We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands ...

With my plump cheeks and petite frame, I'm no stranger to being carded. It's become second nature for me to whip out my I.D.

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Equities researchers at Zacks Research lifted their Q4 2024 earnings estimates for Sarepta Therapeutics in a research note issued to investors on Monday, February 3rd. Zacks Research analyst S.

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The disabled community in Hollywood reminds their able-bodied colleagues to help join in the fight for equality and inclusion ...

Blizzard Entertainment and World of Warcraft players raised over $2 million for CureDuchenne, honoring Mats Steen, a devoted player lost to Duchenne muscular dystrophy, while promoting awareness and ...

Patient advocate Austin Leclaire, who died Feb. 1, played a pivotal role in spurring the development of the first medicines ...

Blizzard's Revenant Pack raises over $2 million for CureDuchenne! Discover how gaming communities made a real-world impact.

Percheron Therapeutics says it will abandon its lead drug candidate altogether, following December's Duchenne muscular dystrophy trial flop.

Despite the obstacles, Riley Herrera had a life filled with family, sports, travel, faith and hope before his death on Nov.